Status: current, Defined. Date: 28-Feb 2023. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4783841000168115 | Olamlo HCT 40/5/25 (amlodipine 5 mg + hydrochlorothiazide 25 mg + olmesartan medoxomil 40 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4783851000168118 | Olamlo HCT 40/5/25 tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Olamlo HCT 40/5/25 tablet, 30 | has TPUU | True | Olamlo HCT 40/5/25 tablet | Inferred relationship | Some | 261573158 |
Olamlo HCT 40/5/25 tablet, 10, blister pack | has TPUU | True | Olamlo HCT 40/5/25 tablet | Inferred relationship | Some | 1957371358 |
Olamlo HCT 40/5/25 tablet, 10 | has TPUU | True | Olamlo HCT 40/5/25 tablet | Inferred relationship | Some | 816175070 |
Olamlo HCT 40/5/25 tablet, 30, blister pack | has TPUU | True | Olamlo HCT 40/5/25 tablet | Inferred relationship | Some | 1277285437 |
Reference Sets
Trade product unit of use reference set